Prelude Therapeutics Ownership | Who Owns Prelude Therapeutics?
Prelude Therapeutics Ownership Summary
Prelude Therapeutics is owned by 44.78% institutional investors, 9.06% insiders, and 46.15% retail investors. Orbimed advisors is the largest institutional shareholder, holding 14.40% of PRLD shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.47% of its assets in Prelude Therapeutics shares.
PRLD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Prelude Therapeutics | 44.78% | 9.06% | 46.15% |
| Sector | Healthcare Stocks | 47.38% | 7.99% | 44.63% |
| Industry | Biotech Stocks | 45.43% | 7.81% | 46.75% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 14.40% | $41.56M |
| Baker bros. advisors lp | 10.12M | 13.37% | $38.57M |
| Deerfield management company, l.p. (series c) | 4.13M | 5.46% | $15.75M |
| Boxer capital | 2.57M | 3.39% | $9.79M |
| Blackrock | 1.07M | 1.41% | $4.07M |
| Vanguard group | 1.01M | 1.33% | $3.85M |
| Price t rowe associates inc /md/ | 891.30K | 1.18% | $3.40M |
| Massachusetts financial services co /ma/ | 522.38K | 0.69% | $1.99M |
| Geode capital management | 361.95K | 0.48% | $1.38M |
| Morgan stanley | 287.35K | 0.38% | $1.09M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Orbimed advisors | 10.91M | 0.83% | $41.56M |
| Boxer capital | 2.57M | 0.52% | $9.79M |
| Baker bros. advisors lp | 10.12M | 0.49% | $38.57M |
| Deerfield management company, l.p. (series c) | 4.13M | 0.26% | $15.75M |
| Bridgeway capital management | 123.60K | 0.01% | $470.92K |
| Exchange traded concepts | 48.73K | 0.00% | $185.65K |
| Y-intercept (hong kong) | 18.84K | 0.00% | $71.78K |
| Renaissance | 206.60K | 0.00% | $787.15K |
| Massachusetts financial services co /ma/ | 522.38K | 0.00% | $1.99M |
| Td asset management | 160.65K | 0.00% | $612.08K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Y-intercept (hong kong) | 18.84K | 0.00% | 18.84K |
| Jacobs levy equity management | 17.76K | 0.00% | 17.76K |
| Dimensional fund advisors lp | 29.07K | - | 14.77K |
| Deutsche bank ag\ | 14.62K | - | 14.62K |
| Massachusetts financial services co /ma/ | 522.38K | 0.00% | 14.23K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Sio capital management | - | - | -320.39K |
| Millennium management | - | - | -101.85K |
| Price t rowe associates inc /md/ | 891.30K | 0.00% | -50.67K |
| Renaissance | 206.60K | 0.00% | -38.20K |
| Kennedy capital management | - | - | -35.28K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Y-intercept (hong kong) | 18.84K | 0.00% | 18.84K | $71.78K |
| Deutsche bank ag\ | 14.62K | - | 14.62K | $55.70K |
| Mirae asset global etfs | 8.13K | 0.00% | 8.13K | $30.99K |
| Corebridge financial | 7.09K | 0.00% | 7.09K | $27.02K |
| Russell investments group | 1.48K | - | 1.48K | $5.64K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -1.00 |
| Nisa investment advisors | -2.10K |
| Qube research | -3.13K |
| American group | -7.33K |
| Prelude capital management | -11.07K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 62 | 6.90% | 33,917,495 | -0.86% | 44 | 1.39% | 25 | 13.64% | 21 | -4.55% |
| Mar 31, 2024 | 58 | 1.75% | 34,212,156 | -1.48% | 56 | 1713434.09% | 22 | -35.29% | 22 | 57.14% |
| Dec 31, 2023 | 57 | -3.39% | 34,725,237 | -5.16% | - | 0.00% | 34 | 13.33% | 14 | -12.50% |
| Sep 30, 2023 | 59 | 7.27% | 36,614,222 | -5.02% | 65 | 1.00% | 30 | -25.00% | 16 | 100.00% |
| Jun 30, 2023 | 55 | - | 38,547,583 | 22.33% | 80 | 1.85% | 40 | 60.00% | 8 | -46.67% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 809.84K | 1.47% | -16.15K |
| Vanguard Total Stock Mkt Idx Inv | 720.43K | 1.31% | - |
| iShares Russell 2000 ETF | 358.70K | 0.65% | -812.00 |
| Biotech Growth Ord | 346.50K | 0.63% | - |
| MFS New Discovery I | 327.70K | 0.60% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 207.51K | 0.38% | - |
| T. Rowe Price Small-Cap Value | 178.09K | 0.32% | -5.49K |
| Fidelity Small Cap Index | 136.41K | 0.25% | -2.31K |
| iShares Russell 2000 Value ETF | 129.45K | 0.24% | - |
| State St Russell Sm/Mid Cp® Indx NL Cl C | 117.50K | 0.21% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 24, 2023 | Vaddi Krishna | CEO | Buy | $5.01K |
| May 25, 2023 | Vaddi Krishna | CEO | Buy | $4.78K |
| May 24, 2023 | Lim Bryant David | Chief Legal Officer, Corp Sec. | Buy | $12.94K |
| May 23, 2023 | Chardonnet Laurent | Chief Financial Officer | Buy | $27.50K |
| May 23, 2023 | Vaddi Krishna | CEO | Buy | $66.75K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | - | - |
| 2024 Q1 | - | - |
| 2023 Q4 | - | - |
| 2023 Q3 | - | - |
| 2023 Q2 | 7 | 1 |
PRLD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools